THE LATEST WORD

Top Industry News – December 14, 2011

Posted on December 14th, 2011 | by Rxmedyn | No Comments »

Angioplasty Safe at Hospitals Without On-Site Surgery: Review

Beware AIDS-Fighting Methods Built on Human Discipline: View

WHO Sets Goal in Fight Against Malaria

States Tough on Abortion Face Legal Costs

FDA Accuses 1-800-GET-THIN of Using Misleading Lap-Band Ads

Read the rest of this entry »

Top Industry News – December 13, 2011

Posted on December 13th, 2011 | by Rxmedyn | No Comments »

Clinical Trials and Social Media – Part 1 in an Intermittent Series

Blink Patterns May Be a Window Into Autistic Mind

No Extra Birth Defect Risk After Cancer Treatment: Study

Many Elderly Screened for Cancer Despite Doubts

FDA Keeps Limits on Other ‘Plan B’ Contraceptive

Read the rest of this entry »

Top Industry News – December 12, 2011

Posted on December 12th, 2011 | by Rxmedyn | No Comments »

Scandal Over Mediator, a French Weight Loss Drug, Prompts Calls for Wide Changes

What is Plan B, Anyway? (And Can Guys Buy It?)

Memory Issues After Cancer May Not Be Due to Chemo

New Method Boosts Blood-Clotting for Hemophiliacs

Tiniest Babies are Growing Up Healthy Despite Odds

Read the rest of this entry »

Top Industry News – December 9, 2011

Posted on December 9th, 2011 | by Rxmedyn | No Comments »

Breast Cancer and Starch: Hold the Pasta

Vitamin D Doesn’t Prevent Heart Attack or Cancer

FDA Panel Backs Overall Benefit of Yaz Pills

Final Toll From Melon Listeria Outbreak: 30 Dead

CDC Issues New TB Treatment Guidelines

Read the rest of this entry »

Top Industry News – December 8, 2011

Posted on December 8th, 2011 | by Rxmedyn | No Comments »

Two Drugs Appear to Delay Progression of  Breast Cancer

Pfizer Kidney Cancer Drug Gets FDA Panel’s Nod

U.S. to Test Therapy to Prevent Birth Defects

Morning-After Pill Curb Is the First Time Ever FDA Overruled by U.S. Chief

FDA Panel Gives Nod to Affymax Drug for Anemia

Read the rest of this entry »

Top Industry News – December 7, 2011

Posted on December 7th, 2011 | by Rxmedyn | No Comments »

“Me-Too” Pharma Firms Will “Disappear” -Roche’s Schwan

Marathons May Damage Part of Heart: Study

Steroids May Boost Survival for Very Preemie Babies

“Viagra in a Condom” May Make Futura a Target

FDA Debates Over-the-Counter Morning-After Pill

Read the rest of this entry »

Top Industry News – December 6, 2011

Posted on December 6th, 2011 | by Rxmedyn | No Comments »

Concerns Over Merger in Pharmacy

Keeping Cold and Flu Germs Out

Americans Urged to Put Flu Shots on Holiday To-Do Lists

Sanofi Announces Positive Results for Diabetes Drug

Extreme Preemies Show Mental Deficits as Adults

Read the rest of this entry »

Top Industry News – December 5, 2011

Posted on December 5th, 2011 | by Rxmedyn | No Comments »

Teva Gains Tentative Approval to Sell Generic Lipitor in 2012

Sickle Cell Disease Tied to  ’Silent Strokes’ in Children

More Children Using Preventive Asthma Drugs: Study

Assisted Suicide Canada Revisits an Old Debate

Bristol-Myers, J&J Team Up Against Hepatitis C

Read the rest of this entry »

Top Industry News – December 2, 2011

Posted on December 5th, 2011 | by Rxmedyn | No Comments »

Court Says Some Donors of Stem Cells Can Be Paid

Low ‘Good’ Cholesterol Doesn’t Cause Heart Attacks

Pfizer, Teva Accused in Suit of Keeping Generic Drug Off Market

Lung Cancer’s Hidden Victims: Those Who Never Smoked

Mylan Develops Generic Birth Control Pill

Read the rest of this entry »

Top Industry News – December 1, 2011

Posted on December 1st, 2011 | by Rxmedyn | No Comments »

World AIDS Day- The Past Cannot Be the Future

Delayed Acyclovir in Neonates With Herpes Ups Mortality

Birth Weight Inversely Impacts Diabetes Risks

Lobular Breast Cancer Linked to Paternal Cancer History

Insight: Diabetes Breakthrough Stalled in Safety Debate

Read the rest of this entry »